Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Aphios Awarded United States Patent

Abstract:
Patent for Compositions and Methods for Inhibiting 5-Alpha Reductase

Aphios Awarded United States Patent

Woburn, MA | Posted on July 27th, 2010

Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for "Compositions and Methods for Inhibiting 5-á Reductase," granted June 29, 2010. This invention is related to compositions and methods for treating diseases involving the 5-alpha (á) reductase enzyme.

5-á reductase is responsible for causing benign prostatic hyperplasia (BPH) and male pattern baldness (alopecia) in men as well as hirsutism (male-pattern body hair) in women. An estimated 50% of men above 50 in the United States have BPH that causes urinary hesitation and frequent urination and night time visits to the bathroom. The incidence of BPH increases to 60% for men over sixty, 70% for men above 70, 80% or men above 80 following an Arrhenius-type plot. BPH has been linked to the incidence of prostate cancer that is the most prevalent cancer among men; and the second leading cause of cancer death among men in the US.

More than 500,000 prostate cancer cases are diagnosed each year in the United States, 1 in 6 American males will develop prostate cancer and 300,000 die of prostate cancer each year.

This invention is utilized in Aphios' SuperCool™ Palmetto and Sperol™ products for several conditions including benign prostatic hyperplasia, prostatic cancer, hirsutism, acne, male pattern baldness, seborrhea, and other androgen hyperactivity diseases. The active pharmaceutical ingredient, finasteride, of Merck's Proscar® for BPH and Propecia® for male pattern baldness work by the same mechanism of 5-á reductase inhibition as SuperCool™ Palmetto and Sperol™, which are natural alternatives to these drugs with fewer side effects.

The source for the active pharmaceutical ingredients in both SuperCool™ Palmetto and Sperol™ is the Serenoa repens (Saw Palmetto) berry.

The therapeutic compositions of the invention were discovered using Aphios' patented SuperFluids™ CXF drug discovery technologies and manufactured using Aphios' patented SuperFluids™ CXP drug manufacturing technologies. These technologies ensure purity, increase extraction efficiency and overall yield, and are environmentally friendly. These technologies are also utilized in Aphios' Zindol® and SuperCool™ Gingerol products for nausea and vomiting, and Xantol™ and SuperCool™ St. John's products for emotional well-being, relaxed outlook, and positive moods.

Research leading to this invention was in part conducted under a SBIR grant 1R43 AT00321-01 from the National Center of Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH). The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of NCCAM and NIH.

####

About Aphios
Aphios®, www.aphios.com and www.SuperCoolHealth.com, is a “green” biotechnology company developing enabling technology platforms for improved drug discovery and manufacturing, nanotechnology drug delivery and pathogenic drug safety. Based on these platforms, we are developing enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders.

For more information, please click here

Contacts:
Trevor P. Castor, Ph.D.
CEO
781-932-6933

Copyright © Aphios

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A compact, efficient single photon source that operates at ambient temperatures on a chip: Highly directional single photon source concept is expected to lead to a significant progress in producing compact, cheap, and efficient sources of quantum information bits for future appls May 3rd, 2016

Nuclear pores captured on film: Using an ultra fast-scanning atomic force microscope, researchers from the University of Basel have filmed 'living' nuclear pore complexes at work for the first time May 3rd, 2016

Little ANTs: Researchers build the world's tiniest engine May 3rd, 2016

An Experiment Seeks to Make Quantum Physics Visible to the Naked Eye May 3rd, 2016

Govt.-Legislation/Regulation/Funding/Policy

A compact, efficient single photon source that operates at ambient temperatures on a chip: Highly directional single photon source concept is expected to lead to a significant progress in producing compact, cheap, and efficient sources of quantum information bits for future appls May 3rd, 2016

Little ANTs: Researchers build the world's tiniest engine May 3rd, 2016

An Experiment Seeks to Make Quantum Physics Visible to the Naked Eye May 3rd, 2016

Making invisible physics visible: The Jayich Lab has created a new sensor technology that captures nanoscale images with high spatial resolution and sensitivity May 2nd, 2016

Nanomedicine

Nuclear pores captured on film: Using an ultra fast-scanning atomic force microscope, researchers from the University of Basel have filmed 'living' nuclear pore complexes at work for the first time May 3rd, 2016

Little ANTs: Researchers build the world's tiniest engine May 3rd, 2016

Non-animal approach to predict impact of nanomaterials on human lung published Archives of Toxicology publishes workshop recommendations May 2nd, 2016

New drug-delivery approach holds potential for treating obesity May 2nd, 2016

Announcements

A compact, efficient single photon source that operates at ambient temperatures on a chip: Highly directional single photon source concept is expected to lead to a significant progress in producing compact, cheap, and efficient sources of quantum information bits for future appls May 3rd, 2016

Nuclear pores captured on film: Using an ultra fast-scanning atomic force microscope, researchers from the University of Basel have filmed 'living' nuclear pore complexes at work for the first time May 3rd, 2016

Little ANTs: Researchers build the world's tiniest engine May 3rd, 2016

An Experiment Seeks to Make Quantum Physics Visible to the Naked Eye May 3rd, 2016

Patents/IP/Tech Transfer/Licensing

System creates on-demand 'nanotube forests,' has potential industry applications April 20th, 2016

Smaller. Cheaper. Better. Iron nitride transformers developed at Sandia could boost energy storage options March 28th, 2016

Correction: Solar fuels: Protective layer for the 'artificial leaf' March 22nd, 2016

New nanoparticle technology to decipher structure and function of membrane proteins March 9th, 2016

Nanobiotechnology

Nuclear pores captured on film: Using an ultra fast-scanning atomic force microscope, researchers from the University of Basel have filmed 'living' nuclear pore complexes at work for the first time May 3rd, 2016

Little ANTs: Researchers build the world's tiniest engine May 3rd, 2016

New drug-delivery approach holds potential for treating obesity May 2nd, 2016

Clay nanotube-biopolymer composite scaffolds for tissue engineering May 1st, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic